BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3784917)

  • 1. Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women.
    Jensen J; Christiansen C; Rødbro P
    Maturitas; 1986 Oct; 8(3):209-16. PubMed ID: 3784917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary oestrogen excretion after the menopause in relation to age and body mass.
    Mole PA; Rae MH; Paterson CR
    Ann Nutr Metab; 1989; 33(5):246-51. PubMed ID: 2624434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen production and metabolism in peri-menopausal women.
    Reed MJ; Beranek PA; James VH
    Maturitas; 1986 Mar; 8(1):29-34. PubMed ID: 3084922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight reduction and oestrogen excretion in obese post-menopausal women.
    de Waard F; Poortman J; de Pedro-Alvarez Ferrero M; Baanders-van Halewijn EA
    Maturitas; 1982 Aug; 4(2):155-62. PubMed ID: 7121295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause.
    Jensen J; Riis BJ; Hummer L; Christiansen C
    Br J Obstet Gynaecol; 1985 Mar; 92(3):260-5. PubMed ID: 3978055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state.
    Wright D; Poller L; Thomson JM; Burrows GE; Hirst CF; Sidebotham A
    Thromb Res; 1997 Mar; 85(6):455-64. PubMed ID: 9101638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
    Whitehead MI; Lane G; Dyer G; Townsend PT; Collins WP; King RJ
    Br J Obstet Gynaecol; 1981 Sep; 88(9):914-8. PubMed ID: 7272264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oestrogen and progestagen on gonadotrophins and sex hormones in oophorectomized women.
    Fink B; Svenstrup B; Bennett P; Micic S; Moller S
    Eur J Obstet Gynecol Reprod Biol; 1988 Feb; 27(2):145-52. PubMed ID: 3125074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Medical Research Council's General Practice Research Framework.
    BMJ; 1996 Feb; 312(7029):473-8. PubMed ID: 8597678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of low-dose estrogen and progestogen on the relief of climacteric symptoms and excretion of urinary calcium].
    Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 1990 Jul; 25(4):198-201, 251. PubMed ID: 2209216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition and muscle performance during menopause and hormone replacement therapy.
    Sipilä S
    J Endocrinol Invest; 2003 Sep; 26(9):893-901. PubMed ID: 14964443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
    Badawy SZ; Elliott LJ; Elbadawi A; Marshall LD
    Br J Obstet Gynaecol; 1979 Jan; 86(1):56-63. PubMed ID: 760768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A; Hassager C; Delmas PD; Christiansen C
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
    Rozenberg S
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):86-91. PubMed ID: 11134831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens.
    Punnonen R; Kilkku P; Kiukko P; Rauramo L
    Maturitas; 1981 Dec; 3(3-4):309-13. PubMed ID: 6278267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women.
    Castracane VD; Kraemer GR; Ogden BW; Kraemer RR
    Maturitas; 2006 Jan; 53(2):217-25. PubMed ID: 15913927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.